Diana Tran
Family Medicine · Milpitas, CANPI 1912571829
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,220, more than ten times the $42 reported in 2023.
Across 59 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$288
- Lilly USA, LLC$193
- AbbVie$176
- Otsuka America Pharmaceutical, Inc.$102
- Pfizer$98
- Xeris Pharmaceuticals, Inc.$72
- plus $443 from 16 others
What the payments were for
- Food & beverage$1,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $288 |
| Lilly USA, LLC | 9 | $193 |
| AbbVie | 7 | $176 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Pfizer | 4 | $98 |
| Xeris Pharmaceuticals, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $62 |
| Boehringer Ingelheim | 2 | $47 |
| Amgen | 3 | $46 |
| Viiv Healthcare Company | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| AstraZeneca | 1 | $26 |
| Exact Sciences | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Lemaitre Vascular, Inc. | 2 | $23 |
| Bayer | 1 | $21 |
| Merck | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| C2n Diagnostics, LLC | 1 | $19 |
| Organon | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Cranial Technologies, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$108
How this compares
$1,371 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 22 | $185 |
| Amlodipine Besylate | 16 | $154 |
| Atorvastatin Calcium | 13 | $144 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Milpitas
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.